BioLife Solutions
BLFS
188 hedge funds and large institutions have $1.12B invested in BioLife Solutions in 2025 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 60 increasing their positions, 62 reducing their positions, and 18 closing their positions.
56% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 18
4% more funds holding
Funds holding: 180 → 188 (+8)
1.56% more ownership
Funds ownership: 100.89% → 102.45% (+1.6%)
3% less repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 62
7% less capital invested
Capital invested by funds: $1.21B → $1.12B (-$90.3M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
98% less call options, than puts
Call options by funds: $65K | Put options by funds: $4.17M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$35.5M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$16.3M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
+$12M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$8.21M |
| 5 |
Rockefeller Capital Management
New York
|
+$3.75M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$19.9M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$8.95M |
| 3 |
CRM
Cramer Rosenthal McGlynn
Stamford,
Connecticut
|
-$5.83M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$5.68M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.39M |
BLFS Hedge Fund Activity: Q1 2025 in Review
188 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q1 2025, worth a combined $1.12B — down 7.4% from $1.21B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new BLFS positions and 18 closed out — a net gain of 10 holders — while 60 added to existing stakes and 62 trimmed.
The largest buyer was T. Rowe Price Investment Management, opening a new position worth an estimated $35.5M. The largest seller was Millennium Management, cutting an estimated $19.9M.
- 188 institutional investors held BioLife Solutions (BLFS) as of Q1 2025, up from 180 in Q4 2024.
- Funds reported $1.12B of BioLife Solutions stock for Q1 2025, down 7.4% quarter-over-quarter.
- 28 funds opened new BioLife Solutions positions in Q1 2025 and 18 closed out, a net change of +10 holders.
- The largest BioLife Solutions buyer in Q1 2025 was T. Rowe Price Investment Management, an estimated $35.5M added.
- The largest BioLife Solutions seller in Q1 2025 was Millennium Management, an estimated $19.9M sold.
Based on aggregated 13F filings for Q1 2025.